Novus Therapeutics, Inc. (NASDAQ:NVUS) has scheduled a conference call for 16th November 2020 at 4:30 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website novustherapeutics.com
To participate on the live call, please dial 877-407-3982 Toll Free, (United States) or 201-493-6780 Outside U.S., with passcode : 13713171
Earnings Expectation
Novus Therapeutics, Inc. is set to announce third quarter earning results on Monday 16th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, NVUS to report 3Q20 loss of $ 1.75 per share. For the full year, analysts anticipate loss of $ 14.4 per share bottom line.
Novus Therapeutics, Inc., a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). The company also has a foam-based drug delivery technology (OP-01) that could be used to deliver drugs into the ear, nose, and sinus cavities.
